@article{Hussain_Naz_Hameed_Aslam_2011, title={GLUCOSE LOWERING EFFECT OF VISFATIN IN OBESE AND INSULIN DEPENDENT DIABETES MELLITUS}, volume={7}, url={https://pjp.pps.org.pk/index.php/PJP/article/view/756}, abstractNote={<p><strong>Background:</strong> Human obesity-related diabetes and the accompanying metabolic disorders have been specifically linked to increased visceral adipose tissue mass. Visfatin (pre-B-cell colony enhancing factor, PBEF) is a novel adipokine that appears to be preferentially produced by visceral adipose tissue that has insulin-mimetic actions. This study investigated if visfatin administration decreases blood glucose in both obese and insulin dependent diabetic mice. <strong>Methods:</strong> One hundred and twenty balb/c strain albino mice were divided into 4 groups. Animals in Group I and Group II were made obese by feeding high fat/high carbohydrate diet whereas Group III and Group IV were made insulin dependent diabetic by injecting streptozotocin. Group I and Group III served as controls whereas Group II and Group IV were administered visfatin injection intravenously as a single bolus dose. Blood samples were collected to measure the blood glucose and visfatin levels. <strong>Results:</strong> Visfatin levels were found increased in obese mice, while administration of recombinant-histidine soluble (mice) visfatin significantly decreased the blood glucose level in obese and insulin dependent diabetic mice (<em>p</em><0.001). <strong>Conclusion:</strong> The glucose lowering effect of visfatin in insulin resistant and insulin dependent diabetic mice is observed.</p>}, number={1}, journal={Pakistan Journal of Physiology}, author={Hussain, Muhammad Mazhar and Naz, Raeesa and Hameed, Waqas and Aslam, Muhammad}, year={2011}, month={Jun.}, pages={4–7} }